肿瘤患者¹²⁵I粒子植入前后机体免疫机能的变化  

Changes of Immune Function in Tumor Patients before and after 125I Seed Implantation

作　　者：詹金花 刘源 宋荣乔 柴文晓[2] 

机构地区：[1]甘肃中医药大学第一临床医学院,甘肃 兰州 [2]甘肃省人民医院肿瘤介入科,甘肃 兰州

出　　处：《临床医学进展》2023年第3期5064-5070,共7页Advances in Clinical Medicine

摘　　要：目的:探讨放射性125I粒子植入对肿瘤患者术后血常规、生化指标的影响。为临床粒子植入治疗肿瘤提供参考依据,并且提高医护人员、患者及患者家属术前、术中及术后的防护意识。方法:选取2015年1月至2020年12月甘肃省人民医院行恶性肿瘤放射性粒子植入术的患者,回顾性分析患者术后1月的血常规及生化指标的变化。结果:患者125I粒子植入术前淋巴细胞计数为(1.08 ± 0.44) × 109/L,术后1月为(0.79 ± 0.42) × 109/L,差异有统计学意义(p 0.05)。生化检查结果如总蛋白、尿酸、胆红素、转氨酶、总胆汁酸、尿酸及血肌酐等,术前及术后1月复查差异均无统计学意义(p > 0.05)。结论:放射性125I粒子植入术后可引起肿瘤患者淋巴细胞计数减低,对其他血常规及生化指标无明显影响。Objective: To investigate the influence of radioactive 125I seed implantation on blood routine and biochemical indexes of tumor patients after operation. It provides reference for clinical seed im-plantation to treat tumor. And improve the awareness of medical staff, patients and patients’ fami-lies before, during and after surgery. Methods: From January 2015 to December 2020, the patients who underwent radioactive seed implantation for malignant tumors in Gansu Provincial People’s Hospital were selected, and the changes of blood routine and biochemical indexes in the first month after surgery were analyzed retrospectively. Results: The lymphocyte count before 125I seed im-plantation was (1.08 ± 0.44) × 109/L, (0.79 ± 0.42) × 109/L 1 month after operation, the difference was statistically significant (p 0.05). Biochemical examination results, such as total protein, uric acid, bilirubin, transaminase, total bile acid, uric acid and serum creatinine, had no significant difference before and 1 month after operation (p > 0.05). Conclusion: Radioactive 125I seed implan-tation can reduce the lymphocyte count of tumor patients, and has no significant impact on other blood routine and biochemical indicators.

关 键 词：¹²⁵I粒子 血常规 生化指标 

分 类 号：R73[医药卫生—肿瘤]